News

Just as the pharma industry is feeling price and margin pressure, so are wholesalers in today’s healthcare marketplace

Both promise and peril exist for drugmakers in working with diagnostic tests to commercialize new medications or refine the applicability of existing ones

A Process-Based Assessment (PBA) is the first step to analyzing reporting needs

Almost three-quarters of physicians have experienced a 'cold chain break' in drugs they've prescribed; less than a third are 'very confident' that the cold chain is being properly managed

New TSA rules mandate inspection of cargo carried on passenger aircraft; manufacturers and others get ‘Certified Cargo Shipping Facility’ status

Will manage ProVision's cyclotron in Tennessee

QPharma’s qSpend IT service provides on-demand access for reporting payments to healthcare practitioners; meanwhile, Cegedim-Dendrite strikes deals with system integrators

Research group finds ‘bad practices’ in current implementations as market grows to $8.5 billion

Newly operational Intellectual Property Enforcement Coordinator (IPEC) issues report calling for drug track-and-trace, stepped-up Customs enforcement

Democratic Energy and Commerce committee member wants better FDA oversight of drug supply chain and material sourcing

Survey shows that 36% of Americans likely to vote have heard of unsafe ingredients

HealthPrize Technologies is readying a sweepstakes approach to encourage patient compliance

Ground-based transportation vehicles will standardize onboard temperature monitors and recorders for cold chain services

New services focus on handling long term care market and customizable marketing support

McKesson flows manufacturer- and payor-sponsored reimbursements into pharmacies for adherence and medication therapy management (MTM) programs

‘Class-wide’ REMS policy will involve patient and prescriber education, but no registry or restricted distribution at this time

18th annual Healthcare Compliance Packaging Council meeting celebrates the benefits of unit-dose packaging

REMS programs need to address stakeholder usability

Healthcare discussions are booming on the Internet. How will FDA allow pharma to participate?

To avoid anti-kickback litigation with government, pharma companies need a defensible position on FMV assessments

Not all managed care plans have the same influence on overall prescribing behavior, and not all geographies operate the same way

More personal control over healthcare and the desire for more access to information drive consumer attitudes

Court rulings begin to swing toward categorizing pharma reps as hourly workers

While staff sales forces continue to shrink, the contract sales business is expected to nearly double over the next five years

Industry’s coming challenges will force dramatic change on how products are brought to market and businesses are sustained. Industry leaders have already started the process

Examining off-label use of highly prescribed drugs reveals factors that differ from the usual criticism of such usage

Dramatic traffic downturn makes providers more eager to offer service options; meanwhile, TSA 100% inspection rule looms for air carriers